MPR delivers practical, up-to-date drug information to healthcare professionals. Using the expertise gained from 25 years of providing point-of-care drug tools, MPR has now created a drug review course exclusively for See below for a list of each quarter's courses. Click here to visit MPR's website.

Latest Courses

Clinical Review

New Drug Review from MPR (April 2014)

1.00 Credits
Clinical Review

New Drug Review from MPR (October 2013)

1.00 Credits

Archived CME/CE Courses


MPR Drug News

InnoPharma Approved for Generic Dacogen

InnoPharma has announced that it has received approval from the Food and Drug Administration (FDA) on its Abbreviated New Drug Application (ANDA) for Decitabine for Injection, a generic version of Eisai's Dacogen.

Ebola Traced to Single Animal Source, Spread at Funeral

The origin of the latest Ebola outbreak has been traced to a single transmission from animal to human that spread during the course of a funeral.

New Biosensor Monitors Vital Signs, Detects Falls

Vital Connect announced that the Food and Drug Administration (FDA) has granted clearance for its HealthPatch MD biosensor for 24-hour patient monitoring in their homes.

Elelyso Gains Pediatric Gaucher Disease Indication

Pfizer and Protalix BioTherapeutics announced that the Food and Drug Administration (FDA) has approved Elelyso (taliglucerase alfa) for injection for pediatric patients.

Pioglitazone, Bladder Cancer Risk: No Link in 10-Year Study

Takeda announced their completion and data submission of a 10-year epidemiology study to regulatory authorities, including the United States Food and Drug Administration (FDA).